Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Moore

Showing results (151-160 of 320) with videos related to

Pageof 32
Sort By:
Journal of Pharmaceutical Sciences|March 4, 2014
Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicidesClaire J Forbes, Clare F McCoy, Diarmaid J Murphy, et al.
The Journal of Antimicrobial Chemotherapy|January 2, 2014
Pharmacokinetics of a CCR5 inhibitor in rhesus macaques following vaginal, rectal and oral applicationR Karl Malcolm, Deborah Lowry, Peter Boyd, et al.
Journal of the American Chemical Society|April 25, 2012
Enhancement of α-helix mimicry by an α/β-peptide foldamer via incorporation of a dense ionic side-chain arrayLisa M Johnson, David E Mortenson, Hyun Gi Yun, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2008
Tropism-independent protection of macaques against vaginal transmission of three SHIVs by the HIV-1 fusion inhibitor T-1249Ronald S Veazey, Thomas A Ketas, Per Johan Klasse, et al.
Virology|March 23, 2004
The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4Pavel Pugach, Shawn E Kuhmann, Joann Taylor, et al.
Virology|September 24, 2004
Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency virusesSteven M Wolinsky, Ronald S Veazey, Kevin J Kunstman, et al.
Virology|June 7, 2005
Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D)Andre J Marozsan, Shawn E Kuhmann, Thomas Morgan, et al.
Molecules (Basel, Switzerland)|April 23, 2020
Oxone<sup>®</sup>-Mediated TEMPO-Oxidized Cellulose Nanomaterials form I and form IIJohn P Moore Ii, Soma Shekar Dachavaram, Shobanbabu Bommagani, et al.
AIDS Research and Human Retroviruses|July 29, 2011
Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in miceKaustuv Banerjee, Elizabeth Michael, Dirk Eggink, et al.
Virology|July 5, 2005
Use of alternate coreceptors on primary cells by two HIV-1 isolatesTonie Cilliers, Samantha Willey, W Mathew Sullivan, et al.
Pageof 32

Showing results (151-160 of 320) with videos related to

Sort By:
Pageof 32
Journal of Pharmaceutical Sciences|March 4, 2014
Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicidesClaire J Forbes, Clare F McCoy, Diarmaid J Murphy, et al.
The Journal of Antimicrobial Chemotherapy|January 2, 2014
Pharmacokinetics of a CCR5 inhibitor in rhesus macaques following vaginal, rectal and oral applicationR Karl Malcolm, Deborah Lowry, Peter Boyd, et al.
Journal of the American Chemical Society|April 25, 2012
Enhancement of α-helix mimicry by an α/β-peptide foldamer via incorporation of a dense ionic side-chain arrayLisa M Johnson, David E Mortenson, Hyun Gi Yun, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2008
Tropism-independent protection of macaques against vaginal transmission of three SHIVs by the HIV-1 fusion inhibitor T-1249Ronald S Veazey, Thomas A Ketas, Per Johan Klasse, et al.
Virology|March 23, 2004
The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4Pavel Pugach, Shawn E Kuhmann, Joann Taylor, et al.
Virology|September 24, 2004
Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency virusesSteven M Wolinsky, Ronald S Veazey, Kevin J Kunstman, et al.
Virology|June 7, 2005
Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D)Andre J Marozsan, Shawn E Kuhmann, Thomas Morgan, et al.
Molecules (Basel, Switzerland)|April 23, 2020
Oxone<sup>®</sup>-Mediated TEMPO-Oxidized Cellulose Nanomaterials form I and form IIJohn P Moore Ii, Soma Shekar Dachavaram, Shobanbabu Bommagani, et al.
AIDS Research and Human Retroviruses|July 29, 2011
Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in miceKaustuv Banerjee, Elizabeth Michael, Dirk Eggink, et al.
Virology|July 5, 2005
Use of alternate coreceptors on primary cells by two HIV-1 isolatesTonie Cilliers, Samantha Willey, W Mathew Sullivan, et al.
Pageof 32